This page in Swedish

Rebecca Wall

Title: Senior Lecturer School/office: School of Medical Sciences

Email:

Phone: +46 19 303383

Room: C3207

Research Subject

Research environments

About Rebecca Wall

Rebecca Wall joined the Nutrition-Gut-Brain Interactions Research Centre in July 2014 as a research associate. She received a Master’s Degree in Chemistry from University of Kalmar, Sweden, in 2003 and a PhD in Microbiology from University College Cork, Ireland, in 2008. Her PhD thesis, entitled ”Metabolic activity of enteric microbiota – implications for host health”, focused on the analysis of microbiota-host interactions and production of bioactive compounds by human intestinal microbes. Rebecca worked as a postdoctoral scientist for 4 years (2009-2013) in Alimentary Pharmabiotic Centre, Ireland, and most of her research during this time involved examining the effects of metabolically active bacterial strains on host fatty acid metabolism and physiology, with a focus on brain function.

Rebeccas research interests includes to understand more about the functions of the microbiota in microbiota-gut-brain-interactions (not just ”who is there” but ”what are they doing”). Her research focuses on the products of bacterial metabolism, such as short chain fatty acids. Butyrate is one of these short chain fatty acids, that is produced in close proximity to our intestinal epithelial cells, by microbial fermentation of undigested dietary fibers. Accumulated literature supports butyrate as being anti-carcinogenic, anti-inflammatory and barrier protective in the distal human gut. In addition, a decrease of butyrate-producing microbes has been inversely associated with colonic disease, including IBD and IBS, supporting the view that butyrate may be a critical determinant of disease resistance. Rebeccas current research aims to understand more about butyrates role in the communication between microbes and the host.

Research Projects

Research Teams

Research Teams

Publications

Publications

Articles in journals |  Articles, reviews/surveys |  Chapters in books |  Conference papers | 

Articles in journals

Wall, R. , Marques, T. , Edebol-Carlman, H. , Sundin, J. , Vumma, R. , Rangel, I. & Brummer, R. J. (2017). Altered expression of membrane transporters in colonic mucosa of patients with Irritable Bowel Syndrome (IBS) and Post-infectious (PI)-IBS compared to healthy subjects. Neurogastroenterology and Motility, 29 (Suppl. 2), 107-108.
Marques, T. M. , Patterson, E. , Wall, R. , O'Sullivan, O. , Fitzgerald, G. F. , Cotter, P. D. , Dinan, T. G. , Cryan, J. F. & et al. (2016). Influence of GABA and GABA-producing Lactobacillus brevis DPC 6108 on the development of diabetes in a streptozotocin rat model. Beneficial Microbes, 7 (3), 409-420.
Marques, T. M. , Wall, R. , O'Sullivan, O. , Fitzgerald, G. F. , Shanahan, F. , Quigley, E. M. , Cotter, P. D. , Cryan, J. F. & et al. (2015). Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. British Journal of Nutrition, 113 (5), 728-738.
Wall, R. , Cryan, J. F. , Ross, R. P. , Fitzgerald, G. F. , Dinan, T. G. & Stanton, C. (2014). Bacterial neuroactive compounds produced by psychobiotics. Advances in Experimental Medicine and Biology, 817, 221-239.
London, L. E. E. , Kumar, A. H. S. , Wall, R. , Casey, P. G. , O'Sullivan, O. , Shanahan, F. , Hill, C. , Cotter, P. D. & et al. (2014). Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. Journal of Nutrition, 144 (12).
Patterson, E. , O' Doherty, R. M. , Murphy, E. F. , Wall, R. , O' Sullivan, O. , Nilaweera, K. , Fitzgerald, G. F. , Cotter, P. D. & et al. (2014). Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. British Journal of Nutrition, 111 (11), 1905-1917.
Wall, R. , Marques, T. M. , O'Sullivan, O. , Ross, R. P. , Shanahan, F. , Quigley, E. M. , Dinan, T. G. , Kiely, B. & et al. (2012). Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. American Journal of Clinical Nutrition, 95 (5), 1278-1287.
Fouhy, F. , Guinane, C. M. , Hussey, S. , Wall, R. , Ryan, C. A. , Dempsey, E. M. , Murphy, B. , Ross, R. P. & et al. (2012). High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrobial Agents and Chemotherapy, 56 (11), 5811-5820.
Hussey, S. , Wall, R. , Gruffman, E. , O'Sullivan, L. , Ryan, C. A. , Murphy, B. , Fitzgerald, G. , Stanton, C. & et al. (2011). Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. International Journal of Microbiology, 2011.
Rosberg-Cody, E. , Stanton, C. , O'Mahony, L. , Wall, R. , Shanahan, F. , Quigley, E. M. , Fitzgerald, G. F. & Ross, R. P. (2011). Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. Microbiology, 157 (2), 609-615.
Wall, R. , Ross, R. P. , Fitzgerald, G. F. & Stanton, C. (2010). Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids.. Nutrition reviews, 68 (5), 280-289.
Wall, R. , Ross, R. P. , Shanahan, F. , O'Mahony, L. , Kiely, B. , Quigley, E. , Dinan, T. G. , Fitzgerald, G. & et al. (2010). Impact of administered bifidobacterium on murine host fatty acid composition. Lipids, 45 (5), 429-436.
Wall, R. , Ross, R. P. , Shanahan, F. , O'Mahony, L. , O'Mahony, C. , Coakley, M. , Hart, O. , Lawlor, P. & et al. (2009). Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. American Journal of Clinical Nutrition, 89 (5), 1393-1401.
Wall, R. , Hussey, S. G. , Ryan, C. A. , O'Neill, M. , Fitzgerald, G. , Stanton, C. & Ross, R. P. (2008). Presence of two Lactobacillus and Bifidobacterium probiotic strains in the neonatal ileum. The ISME Journal, 2 (1), 83-91.
Wall, R. , Fitzgerald, G. , Hussey, S. , Ryan, T. , Murphy, B. , Ross, P. & Stanton, C. (2007). Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and adult gastrointestinal tract. FEMS Microbiology Ecology, 59 (1), 127-137.

Articles, reviews/surveys

Patterson, E. , Wall, R. , Fitzgerald, G. F. , Ross, R. P. & Stanton, C. (2012). Health implications of high dietary omega-6 polyunsaturated fatty acids. Journal of Nutrition and Metabolism, 2012.
Marques, T. M. , Wall, R. , Ross, R. P. , Fitzgerald, G. F. , Ryan, C. A. & Stanton, C. (2010). Programming infant gut microbiota: influence of dietary and environmental factors. Current Opinion in Biotechnology, 21 (2), 149-156.
Wall, R. , Ross, R. P. , Ryan, C. A. , Hussey, S. , Murphy, B. , Fitzgerald, G. F. & Stanton, C. (2009). Role of gut microbiota in early infant development. Clinical Medicine: Pediatrics, 3, 45-54.

Chapters in books

Marques, T. M. , Holster, S. , Wall, R. , König, J. & Brummer, R. J. (2016). Correlating the gut microbiome to health and disease. In: Niall Hyland, Catherine Stanton, The Gut-Brain Axis: Dietary, Probiotic, and Prebiotic Interventions on the Microbiota (pp. 261-291). . Elsevier.

Conference papers

Gorreja, F. , Rangel, I. , Rush, S. , Wall, R. , De Vos, W. M. & Brummer, R. J. (2018). Double-blind cross-over trial reveals human mucosal transcriptome responses to variants of LGG administration in vivo. In: Peter Konturek, Targeting microbiota 6th World congress on targeting microbiota towards clinical revolution. Paper presented at 6th World Congress on Targeting Microbiota, Porto, Portugal, October 28-30, 2018. Porto, Portugal: ISM.
Gorreja, F. , Rush, S. , Marques, T. M. , Repsilber, D. , Baker, A. , Wall, R. & Brummer, R. J. (2018). The impacts of probiotics and prebiotics on the gut mucosa and immune system through targeting inflammation and intestinal barrier function. Paper presented at Food and Inflammation - 2nd Conference of Food Science Sweden, Örebro, Sweden, 21 Nov., 2018.